There are currently 26 active clinical trials seeking participants for Breast Cancer Female research studies. The states with the highest number of trials for Autism participants are NRW, Illinois, Minnesota and Florida.
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
Recruiting
The purpose of this study is to learn whether clinical response (the amount a tumor shrinks based on imaging or tumor measurements obtained by physical exam) predicts pathologic response (the amount of tumor remaining when surgery is performed) in participants with breast cancer who are receiving chemotherapy prior to surgery.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/11/2024
Locations: Harris Health System - Smith Clinic, Houston, Texas +1 locations
Conditions: Breast Cancer, Breast Neoplasm, Breast Cancer Female, Breast Cancer Invasive, Breast Cancer Stage II, Breast Cancer Stage III, Triple Negative Breast Cancer, Hormone Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Neoplasms, Estrogen Receptor-positive Breast Cancer
Ultrahypofractionation and Normal Tissue Toxicity
Recruiting
This research is being done to see if proton beam radiation therapy (PBT) results in fewer changes to a participant's heart measured with MRI-imaging than conventional or "photon" radiation therapy (XRT) for participants with non-metastatic left sided breast cancer. The names of the two study groups in this research study are: Proton Radiation Therapy (PBT) Conventional or "Photon" Radiation Therapy (XRT)
Gender:
Female
Ages:
18 years and above
Trial Updated:
01/11/2024
Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Conditions: Breast Cancer, Breast Cancer Female, Breast Cancer Stage II, Breast Cancer Stage III, Myocardial Fibrosis
Time Restricted Eating During Chemotherapy for Breast Cancer
Recruiting
Breast cancer is the most common cancer in the United States however, little is known about how diet can affect cancer treatment. Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed research will demonstrate that time restricted eating, a form of intermittent fasting, will improve treatment related outcomes, patient related outcomes, and limit treatment related weight gain and fat mass accret... Read More
Gender:
Female
Ages:
Between 25 years and 99 years
Trial Updated:
11/17/2023
Locations: University of Illinois Chicago, Chicago, Illinois
Conditions: Breast Cancer Female
Microbiome and Association With Implant Infections
Recruiting
The most common tissue expander-related infections are from Staphylococcus and Pseudomonas species. In addition, from breast tissue microbiome studies, Staphylococcus and Pseudomonas show variable abundance across samples. The investigator hypothesizes that participants undergoing mastectomy with high initial abundance of Staphylococcus and/or Pseudomonas are more likely to develop subsequent tissue expander-related infections from these respective organisms.
Gender:
Female
Ages:
18 years and above
Trial Updated:
11/15/2023
Locations: University of California, San Francisco, San Francisco, California
Conditions: Breast Cancer, Breast Cancer Female, Genetic Predisposition to Disease
Exploring Cultural Acceptability of Community Breast Cancer Risk Assessment Among Hispanic Women in Maricopa County
Recruiting
This study explores the cultural acceptability of community breast cancer risk assessment among Hispanic women in Maricopa county.
Gender:
Female
Ages:
Between 40 years and 65 years
Trial Updated:
10/31/2023
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona
Conditions: Breast Carcinoma, Breast Cancer, Breast Cancer Female
Biennial CEM in Women With a Personal History of Breast Cancer
Recruiting
This is a prospective clinical trial that will examine if biennial contrast-enhanced mammography added to annual 3D mammography (tomosynthesis) substantially improves breast cancer detection with minimal increase in false-positives, in women with a personal history of breast cancer.
Gender:
Female
Ages:
Between 30 years and 79 years
Trial Updated:
10/23/2023
Locations: UPMC Magee-Womens Imaging - Bethel Park, Bethel Park, Pennsylvania +4 locations
Conditions: Breast Cancer, Breast Neoplasms, Breast Cancer Female, Neoplasms
Breast Cancer Survivor Educational Intervention
Recruiting
The goal of this study is to test a 6-week virtual education program among Black breast cancer survivors. The virtual program includes sessions on physical activity, goal setting, nutrition, sleep, stress, and social connections.
Gender:
Female
Ages:
22 years and above
Trial Updated:
09/22/2023
Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Conditions: Breast Cancer, Breast Neoplasms, Breast Carcinoma, Breast Cancer Female
GammaPod Registry and Quality of Life Nomogram
Recruiting
This study is a prospective, single arm study (registry) summarizing patient-level adverse-event and tumor outcomes as well as a number of feasibility and dosimetric characteristics of delivering a single-fraction boost with the GammaPod.
Gender:
Female
Ages:
18 years and above
Trial Updated:
09/11/2023
Locations: Upper Chesapeake Health, Bel Air, Maryland +3 locations
Conditions: Breast Cancer Female
Metacognitive Strategy Training in Cancer-related Cognitive Impairment
Recruiting
The first aim of this study is to determine the feasibility of delivering CO-OP remotely to breast cancer survivors, who self-report cancer-related cognitive impairment (CRCI), in preparation for a future R01 trial. The second aim of this study is to assess the effect of CO-OP on activity performance, subjective and objective cognition, and quality of life in a sample of breast cancer survivors who self-report CRCI. The research team hypothesizes that effect size estimations will indicate that C... Read More
Gender:
Female
Ages:
Between 40 years and 80 years
Trial Updated:
05/22/2023
Locations: University of Missouri Occupational Therapy Department, Columbia, Missouri
Conditions: Breast Cancer Female
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
Recruiting
To determine the effect of low dose azacitidine therapy on tumor infiltrating lymphocytes (TILs) in primary tumors from patients with high-risk early stage breast cancer, paired t-tests will be first used to compare TIL count in pre- and post-treatment specimens.
Gender:
Female
Ages:
18 years and above
Trial Updated:
05/03/2023
Locations: University of Illinois Cancer Center, Chicago, Illinois
Conditions: Breast Cancer Female, Breast Cancer Invasive
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
Recruiting
Many breast cancer survivors (estimated 70% in some studies) experience clinically significant depression and/or anxiety in the months and years after finishing cancer treatments. This research will build on the rigor of prior research to reduce breast cancer survivor depression and anxiety with a compassion meditation intervention called CBCT (Cognitively-Based Compassion Training) for online synchronous delivery that is also inclusive of informal caregivers (i.e., adult family members who live... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/22/2023
Locations: University of Arizona, Tucson, Arizona
Conditions: Breast Cancer Female, Psychological Distress
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA
Recruiting
The goal of this clinical trial is to learn how a group resistance training plan can improve body mobility and strength in female breast cancer patients who have completed their breast cancer treatment. The main questions it aims to answer are: Is resistance training feasible following breast cancer treatment Can it improve the body's mobility and strength lost as a result of the breast cancer treatment can it improve the body's composition (for example muscle mass) can resistance training incr... Read More
Gender:
Female
Ages:
Between 20 years and 89 years
Trial Updated:
02/25/2023
Locations: Allegheny General Hospital, Pittsburgh, Pennsylvania
Conditions: Breast Cancer Female